An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic PK Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.
Latest Information Update: 04 Apr 2023
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Overseas Pharmaceuticals
Most Recent Events
- 04 Apr 2023 New trial record